eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancer - Concepedia

Concepedia

Publication | Open Access

eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancer

DOI Full Paper Access

47

Citations

33

References

2019

Year

Ruoxi Wang, Xiao‐En Xu, Liang Huang, Sheng Chen, Zhi‐Ming Shao

Annals of Translational Medicine

Abstract

Our study indicated that eEF2K and autophagy play key roles in the maintenance of aggressive tumor behavior and chemoresistance in resistant TNBC. eEF2K silencing may be a novel strategy for the treatment of TNBC.

References

	Year	Citations
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Brian D. Lehmann, Joshua A. Bauer, Xi Chen, Journal of Clinical Investigation Androgen ReceptorBreast OncologyTumor BiologyOncologyTumor Heterogeneity	2011	5.3K
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes Lisa A. Carey, Elizabeth Claire Dees, Lynda Sawyer, Clinical Cancer Research	2007	2.1K
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype Katrina Bauer, Monica Brown, Rosemary D. Cress, Cancer Breast OncologyProgesterone ReceptorEpidemiology Of CancerEstrogen ReceptorGynecology	2007	2K
Isolation and characterization of autophagy‐defective mutants of <i>Saccharomyces cerevisiae</i> Miki Tsukada, Yoshinori Ohsumi FEBS Letters	1993	1.7K
Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes Shigeomi Shimizu, Toku Kanaseki, Noboru Mizushima, Nature Cell Biology Cell AutophagyMitophagyAutoimmune DiseaseAutoantibody ProductionCell Regulation	2004	1.3K
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma Ravi K. Amaravadi, Duonan Yu, Julian J. Lum, Journal of Clinical Investigation	2007	1.1K
Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer Ayca Gucalp, Sara M. Tolaney, Steven J. Isakoff, Clinical Cancer Research	2013	700
Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy Wilfried Bursch, Adolf Ellinger, Harald Kienzl, Carcinogenesis	1996	511
The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation Gabriel Leprivier, Marc Remke, Barak Rotblat, Cell Signal TransductionSignaling PathwayMolecular RegulationNutrient DeprivationCellular Biochemistry	2013	407
Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer José Baselga, Patricia Gómez, Richard Greil, Journal of Clinical Oncology	2013	350

Page 1